Altimmune, Inc. (ALT) Financials
ALT Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 166.6 million | 16.2 million |
2023-06-30 | 183.3 million | 15.6 million |
2023-03-31 | 187.1 million | 19.4 million |
2022-12-31 | 206.9 million | 21.6 million |
ALT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -20.5 million | 2.7 million |
2023-06-30 | -19.4 million | 2.8 million |
2023-03-31 | -19.5 million | 2.7 million |
2022-12-31 | -17.3 million | 1.9 million |
ALT Net Income
No data available :(
ALT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 140.8 million | - | 788000 |
2023-06-30 | 160.0 million | 4.2 million | 903000 |
2023-03-31 | 165.7 million | 4.4 million | 1.0 million |
2022-12-31 | 184.9 million | - | 1.1 million |
ALT Shares Outstanding
ALT Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 18.4 million | 4.5 million | - |
2023-06-30 | 4000 | 13.3 million | 4.8 million | - |
2023-03-31 | 51000 | 17.2 million | 4.5 million | - |
2022-12-31 | 38000 | 19.2 million | 3.8 million | - |
ALT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 362000 | 18.4 million |
2023-06-30 | 6000 | 13.3 million |
2023-03-31 | 21000 | -356000 |
2022-12-31 | -110000 | 110000 |
ALT
Price: $7.19
52 week price:
Earnings Per Share: -1.66 USD
P/E Ratio: -6.75
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 680703
Ebitda: -31.4 millionMarket Capitalization: 567.9 million